2.A new method of measuring the pulse based on facial video.
Feifan ZHAO ; Luping FANG ; Shixiao CHEN
Journal of Biomedical Engineering 2012;29(5):876-918
This paper proposes a new method of non-contact pulse measurement by analyzing a clip of human facial video. The method is based on photo plethysmography (PPG) and independent component analysis (ICA) model. A clip of color facial video shot under normal lighting condition is firstly discomposed into RGB channel sequences. Secondly, by applying ICA to the 3 channel sequences, 3 new independent signals are obtained, among which one signal is close to human pulse wave. Thus the pulse can be measured. In this paper, the principles of PPG and ICA are briefly described and the measurement framework is proposed. The experimental results showed that this novel approach was reasonable and feasible.
Algorithms
;
Analysis of Variance
;
Facies
;
Humans
;
Models, Statistical
;
Photoplethysmography
;
methods
;
Principal Component Analysis
;
methods
;
Pulse
;
Video Recording
;
methods
3.Non-surgical combined modality treatments for laryngeal organ preservation in advanced hypopharyngeal carcinoma.
Xinxin ZHANG ; Jialing WANG ; Wenming WU ; Lin MA ; Mingbo LIU ; Feifan ZHAO ; Deliang HUANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2014;49(7):558-563
OBJECTIVETo investigate the treatment outcome, laryngeal preservation and side-effect in locally advanced hypopharyngeal carcinoma treated with combined Hilical tomotherapy (HT) or intensity-modulated radiotherapy (IMRT) and chemotherapy and/or EGFR inhibitor (Cetuximab or Nimotuzumab).
METHODSA total of 68 patients (20 cases with T1-2N1-3M0 and 48 cases with T3-4N1-3M0) with locally advanced hypopharyngeal cancer were treated individualy with non-surgical combined modality treatments including induction chemotherapy followed by concurrent chemoradiotherapy, induction chemotherapy followed by concurrent radiotherapy and EGFR inhibitor, concurrent chemoradiotherapy and EGFR inhibitor, and concurrent radiotherapy and EGFR inhibitor. HT was used in 40 patients and IMRT in 28 patients. Side-effects were evaluated with the established Common Terminology Criteria for Adverse Events (CTCAE) version 3.0 criteria.
RESULTSThe average follow-up time was 25.7 months (range 3-69 months). All patients completed the planned radiotherapy without treatment breaks, and 66 (97.0%) of 68 patients completed the planned chemotherapy. The 2-year and 3-year overall survival rates were 78.8% and 64.7% respectively, with an organ preservation rate of 84.2%. The most common side-effect greater than or equal to grade 3 was oropharyngeal mucositis. No patient dependent on a percutaneous gastrostomy and tracheostomy tube.
CONCLUSIONHypopharyngeal carcinoma can be treated with non-surgical combined modality treatment including HT or IMRT, with a high laryngeal organ preservation rate and minimal toxicities.
Antibodies, Monoclonal, Humanized ; Antineoplastic Agents ; Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Carcinoma, Squamous Cell ; therapy ; Cetuximab ; Chemoradiotherapy ; Cisplatin ; Combined Modality Therapy ; methods ; Fluorouracil ; Head and Neck Neoplasms ; therapy ; Humans ; Hypopharyngeal Neoplasms ; therapy ; Larynx ; Larynx, Artificial ; Organ Preservation ; Radiotherapy, Intensity-Modulated ; Survival Rate ; Treatment Outcome
4. Biological characteristics and genomic information of a bacteriophage against pan-drug resistant Klebsiella pneumoniae in a burn patient and its effects on bacterial biofilm
Ziyi QI ; Shuoyao YANG ; Shuwen DONG ; Feifan ZHAO ; Jinhong QIN ; Jun XIANG
Chinese Journal of Burns 2020;36(1):14-23
Objective:
To isolate a bacteriophage against pan-drug resistant
5.Clinical analysis of in-patients with large vestibular aqueduct syndrome.
Dayong WANG ; Yali ZHAO ; Feifan ZHAO ; Liang ZONG ; Bing HAN ; Lan LAN ; Qiujing ZHANG ; Yue QI ; Qiuju WANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2013;27(19):1063-1067
OBJECTIVE:
This study is to investigate the clinical materials of in-patients with the large vestibular aqueduct syndrome (LVAS), and explore the feature, diagnosis and treatment measures of the disease.
METHOD:
A retrospective review was conducted including the medical history, audiological examinations, vestibular function examinations, imaging examinations and treatment methods of 44 in patients (87 ears) suffering LVAS admitted to our hospital in the past 4 years(from 2008 to 2012).
RESULT:
ln the 44 in patients, there were 24 male cases and 20 female cases, and the male-female ratio was 1.2 :1. The average of the onset age was 3.39 years. Five cases (11. 36%) had related familial history. The profound hearing loss was found in 67 ears (77.01%), and the severe hearing loss was found in 20 ears (22.99%). After systemic treatment,the hearing of 38 ears improved effectively,but that of 49 ears did not improve obviously. The analysis found that patients suffering sudden hearing loss got better curative effect than those with progressive hearing loss. Patients received combined drug therapy improving arterial circulation as well as venous reflux got better therapeutic effect. There was a significant difference on effect between the patients with course of treatment more than 7 days and those less than 7 days. There was no significant correlation between therapeutic effect and other factors.
CONCLUSION
In part of LVAS patients,the hearing level can be effectively improved through a standard internal medicine treatment. We can improve the personalized and standardized treatment strategy for this disease through analysis of diagnosis and treatment of in-patients with complete clinical data.
Adolescent
;
Adult
;
Child
;
Child, Preschool
;
Female
;
Hearing Loss, Sensorineural
;
diagnosis
;
therapy
;
Humans
;
Infant
;
Inpatients
;
Male
;
Vestibular Aqueduct
;
abnormalities
;
Vestibular Diseases
;
diagnosis
;
therapy
;
Young Adult